Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 377 | 2024 | 11670 | 12.710 |
Why?
|
Stroke Volume | 282 | 2024 | 5496 | 9.360 |
Why?
|
Angiotensin Receptor Antagonists | 97 | 2024 | 1039 | 6.530 |
Why?
|
Tetrazoles | 87 | 2024 | 909 | 6.430 |
Why?
|
Biphenyl Compounds | 99 | 2024 | 1007 | 5.370 |
Why?
|
Ventricular Function, Left | 131 | 2024 | 3879 | 4.740 |
Why?
|
Spironolactone | 41 | 2024 | 412 | 3.940 |
Why?
|
Drug Combinations | 87 | 2024 | 2048 | 3.590 |
Why?
|
Ventricular Dysfunction, Left | 45 | 2024 | 2118 | 3.520 |
Why?
|
Glucosides | 25 | 2024 | 512 | 3.020 |
Why?
|
Benzhydryl Compounds | 33 | 2024 | 916 | 2.880 |
Why?
|
Influenza Vaccines | 23 | 2024 | 768 | 2.880 |
Why?
|
Enalapril | 27 | 2022 | 312 | 2.840 |
Why?
|
Natriuretic Peptide, Brain | 54 | 2024 | 1723 | 2.830 |
Why?
|
Neprilysin | 32 | 2024 | 478 | 2.450 |
Why?
|
Influenza, Human | 25 | 2024 | 1521 | 2.390 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 43 | 2024 | 1516 | 2.200 |
Why?
|
Peptide Fragments | 46 | 2024 | 5112 | 1.680 |
Why?
|
Hospitalization | 74 | 2024 | 10721 | 1.590 |
Why?
|
Myocardial Infarction | 35 | 2024 | 11461 | 1.420 |
Why?
|
Aged | 299 | 2024 | 169310 | 1.370 |
Why?
|
Echocardiography | 43 | 2024 | 4989 | 1.320 |
Why?
|
Diabetes Mellitus, Type 2 | 44 | 2024 | 12148 | 1.310 |
Why?
|
Cardiovascular Diseases | 57 | 2024 | 15501 | 1.290 |
Why?
|
Atherosclerosis | 26 | 2024 | 3408 | 1.260 |
Why?
|
Randomized Controlled Trials as Topic | 37 | 2024 | 10212 | 1.260 |
Why?
|
Cardiomyopathy, Hypertrophic | 10 | 2024 | 1310 | 1.220 |
Why?
|
Humans | 549 | 2024 | 761572 | 1.190 |
Why?
|
Renal Insufficiency, Chronic | 21 | 2024 | 2243 | 1.160 |
Why?
|
Double-Blind Method | 69 | 2024 | 12341 | 1.100 |
Why?
|
Naphthyridines | 5 | 2024 | 143 | 1.090 |
Why?
|
Pulmonary Edema | 7 | 2024 | 409 | 1.080 |
Why?
|
Blood Pressure | 29 | 2023 | 8481 | 1.080 |
Why?
|
Male | 347 | 2024 | 360842 | 1.060 |
Why?
|
Data Interpretation, Statistical | 9 | 2021 | 2691 | 1.050 |
Why?
|
Glomerular Filtration Rate | 23 | 2024 | 2177 | 1.040 |
Why?
|
Troponin T | 11 | 2024 | 780 | 1.030 |
Why?
|
Urea | 9 | 2024 | 443 | 1.020 |
Why?
|
Middle Aged | 256 | 2024 | 220920 | 1.020 |
Why?
|
Atrial Fibrillation | 22 | 2024 | 5127 | 1.020 |
Why?
|
Female | 347 | 2024 | 392686 | 1.000 |
Why?
|
Diabetes Mellitus | 21 | 2024 | 5841 | 0.990 |
Why?
|
Prognosis | 97 | 2024 | 29629 | 0.970 |
Why?
|
Ramipril | 10 | 2024 | 102 | 0.960 |
Why?
|
Treatment Outcome | 119 | 2024 | 64684 | 0.950 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 15 | 2024 | 431 | 0.940 |
Why?
|
Vaccination | 21 | 2024 | 3384 | 0.870 |
Why?
|
Heart Ventricles | 17 | 2024 | 3807 | 0.860 |
Why?
|
Heart Failure, Diastolic | 5 | 2024 | 76 | 0.850 |
Why?
|
Endpoint Determination | 6 | 2019 | 590 | 0.830 |
Why?
|
Hypertension | 23 | 2023 | 8540 | 0.790 |
Why?
|
Aged, 80 and over | 100 | 2024 | 58986 | 0.780 |
Why?
|
Atrial Function, Left | 7 | 2021 | 185 | 0.740 |
Why?
|
Troponin I | 6 | 2024 | 651 | 0.730 |
Why?
|
Heart Atria | 13 | 2022 | 1345 | 0.720 |
Why?
|
Risk Factors | 107 | 2024 | 74213 | 0.710 |
Why?
|
Prospective Studies | 92 | 2024 | 54426 | 0.690 |
Why?
|
Cause of Death | 25 | 2024 | 3683 | 0.670 |
Why?
|
Hematinics | 7 | 2023 | 282 | 0.670 |
Why?
|
Antihypertensive Agents | 13 | 2023 | 2024 | 0.660 |
Why?
|
Acute Coronary Syndrome | 10 | 2023 | 2190 | 0.650 |
Why?
|
Prealbumin | 7 | 2024 | 222 | 0.650 |
Why?
|
Hyperkalemia | 8 | 2023 | 233 | 0.640 |
Why?
|
Risk Assessment | 44 | 2024 | 23996 | 0.630 |
Why?
|
Hypotension | 7 | 2024 | 879 | 0.620 |
Why?
|
Ventricular Remodeling | 14 | 2024 | 1267 | 0.610 |
Why?
|
Cardiomyopathies | 9 | 2024 | 1964 | 0.600 |
Why?
|
Heart Failure, Systolic | 4 | 2023 | 135 | 0.600 |
Why?
|
Benzimidazoles | 6 | 2020 | 858 | 0.600 |
Why?
|
Hypertrophy, Left Ventricular | 9 | 2022 | 851 | 0.600 |
Why?
|
Proportional Hazards Models | 29 | 2024 | 12463 | 0.580 |
Why?
|
Hypoglycemic Agents | 13 | 2024 | 3085 | 0.580 |
Why?
|
Death, Sudden, Cardiac | 7 | 2024 | 1555 | 0.560 |
Why?
|
Stroke | 19 | 2023 | 9758 | 0.560 |
Why?
|
Natriuretic Peptides | 8 | 2023 | 155 | 0.560 |
Why?
|
Kidney | 19 | 2024 | 7047 | 0.560 |
Why?
|
Life Expectancy | 3 | 2018 | 1242 | 0.540 |
Why?
|
Exercise Test | 6 | 2024 | 2127 | 0.540 |
Why?
|
Exercise Tolerance | 6 | 2024 | 836 | 0.530 |
Why?
|
Anemia | 7 | 2024 | 1509 | 0.530 |
Why?
|
Echocardiography, Doppler | 11 | 2020 | 897 | 0.510 |
Why?
|
Amyloid Neuropathies, Familial | 3 | 2023 | 151 | 0.500 |
Why?
|
Kidney Failure, Chronic | 9 | 2024 | 2472 | 0.500 |
Why?
|
Time Factors | 46 | 2024 | 39970 | 0.490 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2018 | 857 | 0.490 |
Why?
|
Quality of Life | 23 | 2024 | 13367 | 0.480 |
Why?
|
Research Design | 9 | 2023 | 6180 | 0.450 |
Why?
|
Angiotensins | 7 | 2024 | 143 | 0.440 |
Why?
|
Hypokalemia | 5 | 2019 | 153 | 0.430 |
Why?
|
Prediabetic State | 4 | 2022 | 545 | 0.430 |
Why?
|
Follow-Up Studies | 50 | 2024 | 39107 | 0.430 |
Why?
|
Ventricular Dysfunction, Right | 4 | 2023 | 628 | 0.420 |
Why?
|
Survival Rate | 27 | 2022 | 12725 | 0.420 |
Why?
|
Diastole | 11 | 2023 | 782 | 0.420 |
Why?
|
Incidence | 36 | 2024 | 21355 | 0.410 |
Why?
|
Diabetic Angiopathies | 4 | 2020 | 803 | 0.410 |
Why?
|
Diuretics | 7 | 2023 | 610 | 0.410 |
Why?
|
Sex Factors | 22 | 2024 | 10553 | 0.400 |
Why?
|
Polypharmacy | 3 | 2024 | 306 | 0.390 |
Why?
|
Proteomics | 6 | 2024 | 3848 | 0.390 |
Why?
|
Coronary Disease | 7 | 2023 | 5914 | 0.370 |
Why?
|
Defibrillators, Implantable | 5 | 2021 | 1490 | 0.360 |
Why?
|
Kaplan-Meier Estimate | 14 | 2024 | 6484 | 0.360 |
Why?
|
Adrenergic beta-Antagonists | 6 | 2023 | 1241 | 0.360 |
Why?
|
Longitudinal Studies | 13 | 2023 | 14607 | 0.350 |
Why?
|
Rectal Neoplasms | 1 | 2019 | 1157 | 0.350 |
Why?
|
Denmark | 8 | 2024 | 771 | 0.350 |
Why?
|
Health Status | 9 | 2024 | 4077 | 0.340 |
Why?
|
Erythropoietin | 3 | 2023 | 719 | 0.340 |
Why?
|
Coronary Artery Disease | 9 | 2023 | 6403 | 0.340 |
Why?
|
Mortality | 9 | 2024 | 2901 | 0.340 |
Why?
|
Systole | 10 | 2023 | 936 | 0.330 |
Why?
|
Diabetic Nephropathies | 5 | 2023 | 973 | 0.330 |
Why?
|
United States | 59 | 2024 | 72335 | 0.330 |
Why?
|
Benzylamines | 6 | 2024 | 247 | 0.330 |
Why?
|
Blood Glucose | 11 | 2024 | 6391 | 0.320 |
Why?
|
Survival Analysis | 12 | 2022 | 10090 | 0.320 |
Why?
|
Heart-Assist Devices | 5 | 2022 | 1287 | 0.320 |
Why?
|
Uracil | 6 | 2024 | 207 | 0.320 |
Why?
|
Amyloidosis | 3 | 2024 | 817 | 0.310 |
Why?
|
Death, Sudden | 3 | 2022 | 301 | 0.300 |
Why?
|
Biometry | 1 | 2011 | 563 | 0.300 |
Why?
|
Peptides | 7 | 2023 | 4358 | 0.290 |
Why?
|
Thiazolidinediones | 1 | 2011 | 461 | 0.290 |
Why?
|
Predictive Value of Tests | 21 | 2024 | 15266 | 0.290 |
Why?
|
Atrial Function, Right | 2 | 2018 | 32 | 0.290 |
Why?
|
Renal Dialysis | 5 | 2023 | 1796 | 0.290 |
Why?
|
Laparoscopy | 1 | 2019 | 2036 | 0.290 |
Why?
|
Propanolamines | 2 | 2018 | 163 | 0.280 |
Why?
|
Heart | 6 | 2023 | 4404 | 0.280 |
Why?
|
Neoplasms | 10 | 2023 | 22173 | 0.280 |
Why?
|
Heart Rate | 8 | 2023 | 4195 | 0.280 |
Why?
|
Cohort Studies | 31 | 2024 | 41493 | 0.280 |
Why?
|
Kidney Diseases | 4 | 2023 | 2091 | 0.270 |
Why?
|
Europe | 11 | 2023 | 3422 | 0.270 |
Why?
|
Clinical Trials as Topic | 10 | 2024 | 8002 | 0.260 |
Why?
|
Gastrointestinal Agents | 2 | 2021 | 510 | 0.260 |
Why?
|
Sex Characteristics | 5 | 2023 | 2639 | 0.250 |
Why?
|
Immunotherapy | 2 | 2018 | 4652 | 0.250 |
Why?
|
Smoking | 8 | 2021 | 9053 | 0.250 |
Why?
|
Furosemide | 3 | 2023 | 170 | 0.250 |
Why?
|
Obesity | 13 | 2022 | 12947 | 0.250 |
Why?
|
Thrombolytic Therapy | 2 | 2023 | 2064 | 0.250 |
Why?
|
Sample Size | 5 | 2017 | 841 | 0.250 |
Why?
|
Intestinal Mucosa | 5 | 2020 | 3032 | 0.250 |
Why?
|
Crohn Disease | 4 | 2021 | 2279 | 0.250 |
Why?
|
Cardiovascular Agents | 2 | 2024 | 840 | 0.250 |
Why?
|
Correspondence as Topic | 1 | 2024 | 35 | 0.240 |
Why?
|
Recurrence | 7 | 2024 | 8466 | 0.240 |
Why?
|
Albuminuria | 5 | 2023 | 657 | 0.240 |
Why?
|
Adult | 58 | 2024 | 221203 | 0.230 |
Why?
|
Comorbidity | 17 | 2021 | 10508 | 0.230 |
Why?
|
Clinical Trials Data Monitoring Committees | 1 | 2024 | 25 | 0.230 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2017 | 1116 | 0.230 |
Why?
|
Coronary Stenosis | 2 | 2020 | 794 | 0.230 |
Why?
|
Heart Arrest | 6 | 2019 | 1514 | 0.220 |
Why?
|
Extracellular Matrix | 3 | 2020 | 1726 | 0.220 |
Why?
|
Matrix Metalloproteinase 2 | 2 | 2023 | 459 | 0.220 |
Why?
|
Dyspnea | 5 | 2023 | 1347 | 0.220 |
Why?
|
Registries | 10 | 2024 | 8224 | 0.220 |
Why?
|
Multiple Sclerosis | 1 | 2018 | 3220 | 0.210 |
Why?
|
Receptors, Angiotensin | 4 | 2024 | 141 | 0.210 |
Why?
|
Echocardiography, Doppler, Color | 2 | 2014 | 352 | 0.210 |
Why?
|
Outpatients | 5 | 2024 | 1597 | 0.210 |
Why?
|
Protease Inhibitors | 2 | 2016 | 754 | 0.210 |
Why?
|
Disease Progression | 16 | 2024 | 13510 | 0.210 |
Why?
|
Electrocardiography | 6 | 2024 | 6377 | 0.210 |
Why?
|
Fumarates | 2 | 2020 | 131 | 0.210 |
Why?
|
Age Factors | 15 | 2024 | 18398 | 0.200 |
Why?
|
Brain Ischemia | 3 | 2023 | 3049 | 0.200 |
Why?
|
Immunization Schedule | 2 | 2024 | 227 | 0.200 |
Why?
|
Dose-Response Relationship, Drug | 12 | 2024 | 10766 | 0.200 |
Why?
|
Myocardium | 5 | 2024 | 4725 | 0.200 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2018 | 555 | 0.190 |
Why?
|
Microscopy, Confocal | 4 | 2016 | 1971 | 0.190 |
Why?
|
Growth Differentiation Factor 15 | 2 | 2024 | 198 | 0.190 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2021 | 3204 | 0.190 |
Why?
|
Amyloidosis, Familial | 1 | 2021 | 16 | 0.190 |
Why?
|
Ferritins | 3 | 2024 | 598 | 0.190 |
Why?
|
Antibody Formation | 2 | 2023 | 1395 | 0.190 |
Why?
|
Potassium | 4 | 2021 | 1311 | 0.190 |
Why?
|
Models, Statistical | 5 | 2020 | 5079 | 0.180 |
Why?
|
Creatinine | 7 | 2024 | 1899 | 0.180 |
Why?
|
Macula Lutea | 1 | 2022 | 177 | 0.180 |
Why?
|
Multiple Myeloma | 1 | 2018 | 5146 | 0.180 |
Why?
|
Diabetes Complications | 3 | 2020 | 1315 | 0.180 |
Why?
|
Amides | 2 | 2020 | 449 | 0.180 |
Why?
|
Hospital Mortality | 9 | 2021 | 5293 | 0.180 |
Why?
|
Ventricular Pressure | 1 | 2021 | 210 | 0.180 |
Why?
|
Placebos | 3 | 2020 | 1667 | 0.180 |
Why?
|
North America | 6 | 2020 | 1276 | 0.180 |
Why?
|
Internationality | 5 | 2019 | 1001 | 0.180 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5672 | 0.170 |
Why?
|
Placebo Effect | 2 | 2015 | 518 | 0.170 |
Why?
|
Biological Factors | 1 | 2021 | 157 | 0.170 |
Why?
|
Edema, Cardiac | 1 | 2019 | 19 | 0.170 |
Why?
|
Multicenter Studies as Topic | 3 | 2021 | 1702 | 0.170 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2019 | 69 | 0.170 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2024 | 353 | 0.170 |
Why?
|
Ultrasonography | 8 | 2021 | 5972 | 0.170 |
Why?
|
Vital Capacity | 2 | 2022 | 971 | 0.170 |
Why?
|
Hemostasis, Endoscopic | 2 | 2017 | 41 | 0.170 |
Why?
|
Metformin | 2 | 2019 | 906 | 0.170 |
Why?
|
Diuretics, Osmotic | 1 | 2019 | 33 | 0.160 |
Why?
|
Hypercholesterolemia | 2 | 2018 | 1141 | 0.160 |
Why?
|
Severity of Illness Index | 16 | 2021 | 15843 | 0.160 |
Why?
|
Drug Labeling | 1 | 2021 | 248 | 0.160 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2019 | 111 | 0.160 |
Why?
|
Hyperaldosteronism | 1 | 2022 | 247 | 0.160 |
Why?
|
Cardiac Myosins | 3 | 2024 | 128 | 0.160 |
Why?
|
International Classification of Diseases | 2 | 2021 | 909 | 0.160 |
Why?
|
Mannitol | 1 | 2019 | 180 | 0.160 |
Why?
|
Heart Diseases | 2 | 2022 | 2781 | 0.160 |
Why?
|
Sodium-Glucose Transporter 1 | 1 | 2018 | 108 | 0.160 |
Why?
|
Models, Cardiovascular | 1 | 2024 | 981 | 0.160 |
Why?
|
C-Reactive Protein | 6 | 2024 | 3826 | 0.150 |
Why?
|
Body Mass Index | 8 | 2022 | 12954 | 0.150 |
Why?
|
HIV Infections | 4 | 2024 | 17352 | 0.150 |
Why?
|
Atrial Appendage | 1 | 2022 | 283 | 0.150 |
Why?
|
Hyperemia | 1 | 2019 | 221 | 0.150 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2019 | 122 | 0.150 |
Why?
|
Valine | 3 | 2014 | 408 | 0.150 |
Why?
|
Pneumonia | 3 | 2024 | 2143 | 0.150 |
Why?
|
Kidney Transplantation | 3 | 2018 | 4235 | 0.150 |
Why?
|
Uric Acid | 2 | 2023 | 807 | 0.150 |
Why?
|
Acute Disease | 7 | 2024 | 7237 | 0.150 |
Why?
|
Critical Care | 2 | 2021 | 2697 | 0.150 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 518 | 0.150 |
Why?
|
Vasodilator Agents | 4 | 2023 | 973 | 0.150 |
Why?
|
Patient Readmission | 3 | 2024 | 3271 | 0.150 |
Why?
|
Canrenone | 1 | 2017 | 5 | 0.150 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2018 | 208 | 0.140 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2024 | 1050 | 0.140 |
Why?
|
Intestinal Absorption | 1 | 2018 | 400 | 0.140 |
Why?
|
Cardiac Volume | 1 | 2018 | 197 | 0.140 |
Why?
|
Virus Diseases | 1 | 2023 | 718 | 0.140 |
Why?
|
Ileum | 3 | 2020 | 557 | 0.140 |
Why?
|
Apolipoprotein E4 | 1 | 2021 | 709 | 0.140 |
Why?
|
Retinal Vessels | 2 | 2022 | 852 | 0.140 |
Why?
|
Adiposity | 2 | 2018 | 1879 | 0.140 |
Why?
|
Myocardial Contraction | 3 | 2024 | 1515 | 0.140 |
Why?
|
Estradiol | 1 | 2024 | 1937 | 0.140 |
Why?
|
Blood Urea Nitrogen | 1 | 2017 | 186 | 0.140 |
Why?
|
Area Under Curve | 2 | 2018 | 1638 | 0.140 |
Why?
|
Sleep Apnea, Obstructive | 3 | 2015 | 1875 | 0.140 |
Why?
|
Hypoglycemia | 2 | 2022 | 883 | 0.140 |
Why?
|
Cross-Sectional Studies | 14 | 2024 | 26127 | 0.140 |
Why?
|
Digoxin | 2 | 2022 | 246 | 0.140 |
Why?
|
Pleural Effusion | 1 | 2020 | 341 | 0.140 |
Why?
|
Duodenal Diseases | 1 | 2017 | 100 | 0.140 |
Why?
|
beta Carotene | 1 | 2018 | 523 | 0.140 |
Why?
|
Retrospective Studies | 26 | 2023 | 80646 | 0.140 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 3 | 2023 | 152 | 0.130 |
Why?
|
Hyperglycemia | 3 | 2020 | 1376 | 0.130 |
Why?
|
Blood Pressure Determination | 1 | 2020 | 633 | 0.130 |
Why?
|
Proton Pump Inhibitors | 1 | 2021 | 532 | 0.130 |
Why?
|
Multivariate Analysis | 10 | 2020 | 12059 | 0.130 |
Why?
|
Hemoglobins | 2 | 2023 | 1526 | 0.130 |
Why?
|
Esophageal Diseases | 1 | 2017 | 168 | 0.130 |
Why?
|
Russia | 4 | 2018 | 384 | 0.130 |
Why?
|
Retinal Artery | 1 | 2016 | 109 | 0.130 |
Why?
|
Troponin | 1 | 2019 | 502 | 0.130 |
Why?
|
Gout | 1 | 2023 | 621 | 0.130 |
Why?
|
Health Status Disparities | 2 | 2018 | 1852 | 0.130 |
Why?
|
Young Adult | 18 | 2024 | 59255 | 0.130 |
Why?
|
Stomach Diseases | 1 | 2017 | 134 | 0.130 |
Why?
|
Chronic Disease | 8 | 2024 | 9319 | 0.130 |
Why?
|
Vascular Resistance | 2 | 2015 | 930 | 0.130 |
Why?
|
Pandemics | 5 | 2023 | 8656 | 0.130 |
Why?
|
Chi-Square Distribution | 6 | 2017 | 3416 | 0.130 |
Why?
|
Therapeutics | 1 | 2015 | 113 | 0.120 |
Why?
|
Glucose Tolerance Test | 1 | 2018 | 1178 | 0.120 |
Why?
|
Myocardial Ischemia | 2 | 2023 | 2113 | 0.120 |
Why?
|
Calcinosis | 1 | 2024 | 1469 | 0.120 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2020 | 575 | 0.120 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2015 | 108 | 0.120 |
Why?
|
Prehypertension | 1 | 2015 | 63 | 0.120 |
Why?
|
Longevity | 2 | 2020 | 1065 | 0.120 |
Why?
|
Heart Valve Diseases | 1 | 2022 | 1027 | 0.120 |
Why?
|
Diabetic Neuropathies | 1 | 2018 | 405 | 0.120 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1927 | 0.120 |
Why?
|
Guidelines as Topic | 1 | 2021 | 1386 | 0.120 |
Why?
|
Prevalence | 11 | 2020 | 15732 | 0.120 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2015 | 61 | 0.120 |
Why?
|
Insulin | 3 | 2018 | 6597 | 0.120 |
Why?
|
Alcohol Drinking | 3 | 2019 | 4028 | 0.120 |
Why?
|
Captopril | 1 | 2015 | 265 | 0.120 |
Why?
|
Lung | 7 | 2023 | 10002 | 0.120 |
Why?
|
Exercise | 4 | 2019 | 5890 | 0.120 |
Why?
|
Aging | 3 | 2020 | 8711 | 0.110 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1231 | 0.110 |
Why?
|
Hypertension, Pulmonary | 2 | 2015 | 1578 | 0.110 |
Why?
|
Echocardiography, Three-Dimensional | 2 | 2018 | 607 | 0.110 |
Why?
|
Ventricular Fibrillation | 1 | 2017 | 537 | 0.110 |
Why?
|
Insulin Resistance | 2 | 2021 | 3963 | 0.110 |
Why?
|
Hemagglutination Inhibition Tests | 2 | 2024 | 85 | 0.110 |
Why?
|
Patient Dropouts | 1 | 2016 | 412 | 0.110 |
Why?
|
Endoscopy, Digestive System | 1 | 2016 | 351 | 0.110 |
Why?
|
Tissue Survival | 1 | 2014 | 119 | 0.110 |
Why?
|
Aortic Valve | 1 | 2024 | 1955 | 0.110 |
Why?
|
Delivery, Obstetric | 1 | 2021 | 940 | 0.110 |
Why?
|
Hemodynamics | 4 | 2021 | 4160 | 0.110 |
Why?
|
Ankle Brachial Index | 1 | 2014 | 163 | 0.110 |
Why?
|
Geriatric Assessment | 2 | 2019 | 1410 | 0.110 |
Why?
|
Electric Countershock | 1 | 2017 | 533 | 0.110 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2115 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.110 |
Why?
|
Drug Therapy, Combination | 6 | 2020 | 6312 | 0.110 |
Why?
|
Dietary Carbohydrates | 1 | 2018 | 891 | 0.110 |
Why?
|
Forced Expiratory Volume | 1 | 2018 | 1814 | 0.110 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1664 | 0.110 |
Why?
|
Coronary Artery Bypass | 1 | 2022 | 2188 | 0.110 |
Why?
|
Frail Elderly | 1 | 2018 | 765 | 0.110 |
Why?
|
Cost of Illness | 2 | 2024 | 1936 | 0.110 |
Why?
|
Algorithms | 4 | 2024 | 14032 | 0.110 |
Why?
|
Gastric Mucosa | 1 | 2016 | 604 | 0.110 |
Why?
|
Patients | 2 | 2021 | 907 | 0.100 |
Why?
|
Georgia (Republic) | 3 | 2018 | 39 | 0.100 |
Why?
|
Malnutrition | 1 | 2019 | 645 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3086 | 0.100 |
Why?
|
Government | 2 | 2023 | 161 | 0.100 |
Why?
|
Colitis, Ulcerative | 2 | 2017 | 1922 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3206 | 0.100 |
Why?
|
Argentina | 3 | 2018 | 246 | 0.100 |
Why?
|
Aftercare | 3 | 2023 | 914 | 0.100 |
Why?
|
Colonoscopy | 2 | 2020 | 1394 | 0.100 |
Why?
|
Drug Therapy | 1 | 2015 | 503 | 0.100 |
Why?
|
Influenza A virus | 1 | 2015 | 458 | 0.100 |
Why?
|
Case-Control Studies | 9 | 2024 | 22176 | 0.100 |
Why?
|
Colchicine | 2 | 2023 | 259 | 0.100 |
Why?
|
Peripheral Arterial Disease | 1 | 2023 | 1273 | 0.100 |
Why?
|
Oxygen Consumption | 3 | 2024 | 1866 | 0.100 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 687 | 0.100 |
Why?
|
Meta-Analysis as Topic | 2 | 2021 | 1380 | 0.100 |
Why?
|
Computer Simulation | 4 | 2018 | 6241 | 0.100 |
Why?
|
Nervous System | 1 | 2015 | 545 | 0.100 |
Why?
|
Antibodies, Viral | 4 | 2024 | 3156 | 0.100 |
Why?
|
Adolescent | 14 | 2024 | 88324 | 0.100 |
Why?
|
Social Behavior | 1 | 2018 | 1135 | 0.100 |
Why?
|
Sweden | 3 | 2020 | 1379 | 0.100 |
Why?
|
Canada | 4 | 2018 | 2122 | 0.100 |
Why?
|
Malaria | 1 | 2021 | 1227 | 0.100 |
Why?
|
Aortic Valve Stenosis | 1 | 2024 | 2001 | 0.090 |
Why?
|
Vaccines, Inactivated | 2 | 2023 | 179 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2021 | 1157 | 0.090 |
Why?
|
Radiotherapy | 1 | 2018 | 1499 | 0.090 |
Why?
|
Coronary Angiography | 2 | 2020 | 4471 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2024 | 1866 | 0.090 |
Why?
|
Los Angeles | 2 | 2022 | 243 | 0.090 |
Why?
|
Income | 1 | 2019 | 1877 | 0.090 |
Why?
|
Heart Transplantation | 2 | 2022 | 3233 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3205 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 1881 | 0.090 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2017 | 874 | 0.090 |
Why?
|
New York | 2 | 2023 | 874 | 0.090 |
Why?
|
Pulmonary Circulation | 2 | 2024 | 737 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 3 | 2015 | 5672 | 0.090 |
Why?
|
Health Status Indicators | 1 | 2015 | 970 | 0.090 |
Why?
|
Cardiology | 1 | 2021 | 1656 | 0.090 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1600 | 0.090 |
Why?
|
Renal Insufficiency | 1 | 2016 | 809 | 0.090 |
Why?
|
RNA, Small Interfering | 1 | 2019 | 3430 | 0.090 |
Why?
|
Cognition | 2 | 2024 | 6992 | 0.090 |
Why?
|
Single-Blind Method | 3 | 2019 | 1574 | 0.080 |
Why?
|
Thromboembolism | 1 | 2016 | 995 | 0.080 |
Why?
|
Drug Monitoring | 3 | 2020 | 962 | 0.080 |
Why?
|
Patient Compliance | 1 | 2020 | 2690 | 0.080 |
Why?
|
Lung Diseases | 1 | 2019 | 1909 | 0.080 |
Why?
|
Diabetic Retinopathy | 1 | 2018 | 1274 | 0.080 |
Why?
|
Procollagen | 2 | 2023 | 187 | 0.080 |
Why?
|
Patient Selection | 3 | 2017 | 4244 | 0.080 |
Why?
|
Up-Regulation | 4 | 2021 | 4124 | 0.080 |
Why?
|
Extracellular Space | 1 | 2011 | 563 | 0.080 |
Why?
|
Breast Feeding | 1 | 2017 | 1360 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2021 | 2151 | 0.080 |
Why?
|
Morbidity | 3 | 2020 | 1750 | 0.080 |
Why?
|
Forecasting | 1 | 2018 | 2928 | 0.080 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 1068 | 0.080 |
Why?
|
Benzamides | 1 | 2014 | 1370 | 0.080 |
Why?
|
Brazil | 3 | 2018 | 1230 | 0.080 |
Why?
|
Acupuncture Therapy | 1 | 2013 | 486 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1998 | 0.080 |
Why?
|
Epithelial Cells | 2 | 2021 | 3677 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2020 | 3066 | 0.080 |
Why?
|
Patient Discharge | 4 | 2023 | 3443 | 0.080 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2012 | 774 | 0.070 |
Why?
|
Risk | 5 | 2018 | 9610 | 0.070 |
Why?
|
Triglycerides | 3 | 2021 | 2461 | 0.070 |
Why?
|
Metabolomics | 1 | 2017 | 1659 | 0.070 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2023 | 364 | 0.070 |
Why?
|
Irritable Bowel Syndrome | 1 | 2013 | 455 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2017 | 3359 | 0.070 |
Why?
|
Sodium | 2 | 2022 | 1588 | 0.070 |
Why?
|
Population Surveillance | 1 | 2017 | 2598 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2018 | 3415 | 0.070 |
Why?
|
Catheter Ablation | 1 | 2020 | 2751 | 0.070 |
Why?
|
Aspirin | 1 | 2018 | 3133 | 0.070 |
Why?
|
Ventricular Function, Right | 2 | 2023 | 617 | 0.060 |
Why?
|
Odds Ratio | 4 | 2019 | 9646 | 0.060 |
Why?
|
Arrhythmias, Cardiac | 2 | 2013 | 2244 | 0.060 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5790 | 0.060 |
Why?
|
Body Weight | 1 | 2016 | 4618 | 0.060 |
Why?
|
Linear Models | 4 | 2017 | 5872 | 0.060 |
Why?
|
Medication Adherence | 1 | 2017 | 2176 | 0.060 |
Why?
|
Glucose | 3 | 2022 | 4346 | 0.060 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20099 | 0.060 |
Why?
|
Japan | 2 | 2020 | 1378 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3245 | 0.060 |
Why?
|
Blood Proteins | 2 | 2023 | 1173 | 0.060 |
Why?
|
Depression | 2 | 2021 | 8124 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2022 | 5440 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2016 | 2422 | 0.060 |
Why?
|
Cost-Benefit Analysis | 3 | 2024 | 5492 | 0.060 |
Why?
|
Sodium-Glucose Transport Proteins | 1 | 2024 | 13 | 0.060 |
Why?
|
Administration, Intravaginal | 1 | 2024 | 150 | 0.060 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2024 | 44 | 0.060 |
Why?
|
Kidney Function Tests | 2 | 2017 | 679 | 0.060 |
Why?
|
Valsalva Maneuver | 1 | 2024 | 99 | 0.060 |
Why?
|
Piperazines | 1 | 2014 | 2523 | 0.060 |
Why?
|
Anti-Retroviral Agents | 2 | 2024 | 1784 | 0.060 |
Why?
|
American Heart Association | 2 | 2021 | 1039 | 0.060 |
Why?
|
Kansas | 1 | 2023 | 37 | 0.060 |
Why?
|
Europe, Eastern | 1 | 2023 | 72 | 0.050 |
Why?
|
Heterozygote | 2 | 2024 | 2787 | 0.050 |
Why?
|
Adrenomedullin | 1 | 2023 | 85 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2017 | 15633 | 0.050 |
Why?
|
Hypovolemia | 1 | 2023 | 48 | 0.050 |
Why?
|
Physical Examination | 2 | 2019 | 1255 | 0.050 |
Why?
|
Aptamers, Nucleotide | 1 | 2024 | 165 | 0.050 |
Why?
|
Colon | 1 | 2011 | 1792 | 0.050 |
Why?
|
Mineralocorticoids | 1 | 2022 | 37 | 0.050 |
Why?
|
Renin-Angiotensin System | 2 | 2018 | 737 | 0.050 |
Why?
|
Fibrosis | 2 | 2023 | 2049 | 0.050 |
Why?
|
Organ Size | 2 | 2020 | 2254 | 0.050 |
Why?
|
Barbiturates | 1 | 2022 | 113 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11076 | 0.050 |
Why?
|
Pyrimidines | 1 | 2014 | 3028 | 0.050 |
Why?
|
Carbamates | 1 | 2024 | 191 | 0.050 |
Why?
|
Cholesterol | 2 | 2021 | 2904 | 0.050 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2024 | 261 | 0.050 |
Why?
|
Pain | 2 | 2015 | 5073 | 0.050 |
Why?
|
Activities of Daily Living | 2 | 2023 | 2421 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 15936 | 0.050 |
Why?
|
Electronics | 1 | 2023 | 318 | 0.050 |
Why?
|
Stress, Mechanical | 2 | 2017 | 1674 | 0.050 |
Why?
|
Child | 7 | 2024 | 80156 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2023 | 5247 | 0.050 |
Why?
|
Psychomotor Agitation | 1 | 2023 | 305 | 0.050 |
Why?
|
Glycine | 1 | 2024 | 663 | 0.040 |
Why?
|
Oligonucleotides | 1 | 2023 | 582 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2023 | 4544 | 0.040 |
Why?
|
ROC Curve | 2 | 2019 | 3579 | 0.040 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2021 | 151 | 0.040 |
Why?
|
Amyloidogenic Proteins | 1 | 2021 | 151 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2021 | 8601 | 0.040 |
Why?
|
Atrial Flutter | 1 | 2022 | 252 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2023 | 3713 | 0.040 |
Why?
|
Renin | 1 | 2022 | 641 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2024 | 829 | 0.040 |
Why?
|
Hypertonic Solutions | 1 | 2019 | 82 | 0.040 |
Why?
|
Erythropoiesis | 1 | 2023 | 683 | 0.040 |
Why?
|
Causality | 2 | 2016 | 1242 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2023 | 1126 | 0.040 |
Why?
|
Nebulizers and Vaporizers | 1 | 2019 | 139 | 0.040 |
Why?
|
Quebec | 1 | 2018 | 141 | 0.040 |
Why?
|
Americas | 1 | 2018 | 111 | 0.040 |
Why?
|
Treatment Failure | 2 | 2015 | 2644 | 0.040 |
Why?
|
Microcirculation | 1 | 2023 | 1272 | 0.040 |
Why?
|
Tomography | 1 | 2020 | 411 | 0.040 |
Why?
|
Biological Availability | 1 | 2019 | 390 | 0.040 |
Why?
|
Regression Analysis | 2 | 2018 | 6344 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2021 | 642 | 0.040 |
Why?
|
Immunoglobulin M | 1 | 2023 | 1526 | 0.040 |
Why?
|
Medication Therapy Management | 1 | 2019 | 130 | 0.040 |
Why?
|
Polyneuropathies | 1 | 2019 | 137 | 0.040 |
Why?
|
Angioedema | 1 | 2019 | 184 | 0.040 |
Why?
|
Polysomnography | 2 | 2015 | 1848 | 0.040 |
Why?
|
Tissue Plasminogen Activator | 1 | 2023 | 1164 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 851 | 0.040 |
Why?
|
Precipitating Factors | 1 | 2017 | 51 | 0.040 |
Why?
|
South Africa | 1 | 2023 | 1843 | 0.040 |
Why?
|
Hot Temperature | 2 | 2015 | 1440 | 0.040 |
Why?
|
Disease Management | 2 | 2021 | 2508 | 0.040 |
Why?
|
Aldosterone | 1 | 2022 | 870 | 0.040 |
Why?
|
Demography | 1 | 2022 | 1648 | 0.040 |
Why?
|
Residence Characteristics | 2 | 2019 | 2094 | 0.040 |
Why?
|
Cerebral Infarction | 1 | 2022 | 983 | 0.040 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2024 | 1351 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2021 | 676 | 0.030 |
Why?
|
Fluorescein Angiography | 1 | 2022 | 1059 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2019 | 1157 | 0.030 |
Why?
|
Ontario | 1 | 2017 | 398 | 0.030 |
Why?
|
Myocarditis | 1 | 2024 | 788 | 0.030 |
Why?
|
Preventive Health Services | 1 | 2021 | 567 | 0.030 |
Why?
|
Photography | 1 | 2019 | 532 | 0.030 |
Why?
|
Bronchodilator Agents | 1 | 2019 | 512 | 0.030 |
Why?
|
Glycoproteins | 1 | 2024 | 2203 | 0.030 |
Why?
|
Administration, Oral | 1 | 2024 | 4021 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2019 | 728 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2021 | 1444 | 0.030 |
Why?
|
Protein Precursors | 1 | 2020 | 1132 | 0.030 |
Why?
|
Netherlands | 1 | 2020 | 2221 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2023 | 1733 | 0.030 |
Why?
|
Genetic Variation | 2 | 2023 | 6567 | 0.030 |
Why?
|
Pulmonary Ventilation | 1 | 2017 | 372 | 0.030 |
Why?
|
Death | 1 | 2020 | 676 | 0.030 |
Why?
|
Retreatment | 1 | 2017 | 598 | 0.030 |
Why?
|
Nursing Homes | 1 | 2023 | 1082 | 0.030 |
Why?
|
Spirometry | 1 | 2018 | 929 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13642 | 0.030 |
Why?
|
Self Efficacy | 1 | 2019 | 638 | 0.030 |
Why?
|
Death Certificates | 1 | 2015 | 167 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 2018 | 539 | 0.030 |
Why?
|
South America | 1 | 2014 | 179 | 0.030 |
Why?
|
Child, Preschool | 3 | 2024 | 42230 | 0.030 |
Why?
|
Periaqueductal Gray | 1 | 2015 | 110 | 0.030 |
Why?
|
Leisure Activities | 1 | 2016 | 308 | 0.030 |
Why?
|
Diet Surveys | 1 | 2018 | 1162 | 0.030 |
Why?
|
Pilot Projects | 2 | 2019 | 8633 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1787 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 2218 | 0.030 |
Why?
|
Seasons | 1 | 2020 | 1520 | 0.030 |
Why?
|
Capsaicin | 1 | 2015 | 231 | 0.030 |
Why?
|
Stochastic Processes | 1 | 2015 | 355 | 0.030 |
Why?
|
Galectin 3 | 1 | 2016 | 240 | 0.030 |
Why?
|
HIV-1 | 2 | 2024 | 6863 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2023 | 2084 | 0.030 |
Why?
|
Drug Substitution | 1 | 2016 | 290 | 0.030 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2014 | 174 | 0.030 |
Why?
|
Plasma | 1 | 2017 | 586 | 0.030 |
Why?
|
Pain Perception | 1 | 2015 | 196 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14666 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 2017 | 1147 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2017 | 1541 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2017 | 13382 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 17904 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2330 | 0.030 |
Why?
|
Caspases | 1 | 2016 | 879 | 0.030 |
Why?
|
Acupuncture Points | 1 | 2013 | 111 | 0.030 |
Why?
|
Galectins | 1 | 2016 | 295 | 0.030 |
Why?
|
Radiology, Interventional | 1 | 2017 | 476 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2018 | 1007 | 0.030 |
Why?
|
Phenotype | 2 | 2024 | 16592 | 0.030 |
Why?
|
Inflammation | 2 | 2024 | 10773 | 0.030 |
Why?
|
Waist Circumference | 1 | 2016 | 935 | 0.030 |
Why?
|
Independent Living | 1 | 2016 | 579 | 0.030 |
Why?
|
Cardiovascular System | 1 | 2020 | 834 | 0.030 |
Why?
|
Australia | 1 | 2016 | 1250 | 0.020 |
Why?
|
Propensity Score | 1 | 2019 | 1913 | 0.020 |
Why?
|
Drug Resistance | 1 | 2018 | 1596 | 0.020 |
Why?
|
Lidocaine | 1 | 2015 | 538 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2018 | 2571 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2016 | 1085 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2759 | 0.020 |
Why?
|
Patient Care Team | 1 | 2023 | 2521 | 0.020 |
Why?
|
Logistic Models | 2 | 2016 | 13255 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2548 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2018 | 2358 | 0.020 |
Why?
|
Angina, Unstable | 1 | 2015 | 888 | 0.020 |
Why?
|
Action Potentials | 1 | 2019 | 1834 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3810 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3306 | 0.020 |
Why?
|
Neutrophils | 1 | 2023 | 3767 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2321 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2024 | 4937 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2013 | 588 | 0.020 |
Why?
|
Pregnancy | 2 | 2023 | 29876 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1188 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2922 | 0.020 |
Why?
|
Reference Values | 1 | 2017 | 4920 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2013 | 370 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2018 | 993 | 0.020 |
Why?
|
Benzazepines | 1 | 2012 | 310 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2017 | 2707 | 0.020 |
Why?
|
Sex Distribution | 1 | 2015 | 2281 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2018 | 1897 | 0.020 |
Why?
|
Pain Threshold | 1 | 2013 | 604 | 0.020 |
Why?
|
Acetaminophen | 1 | 2013 | 554 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2022 | 2917 | 0.020 |
Why?
|
Viral Load | 1 | 2018 | 3332 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6766 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2015 | 1814 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3335 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4243 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2024 | 4527 | 0.020 |
Why?
|
Cues | 1 | 2013 | 875 | 0.020 |
Why?
|
Iron | 1 | 2016 | 1793 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2019 | 1940 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2015 | 1403 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2273 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2015 | 997 | 0.020 |
Why?
|
Health Behavior | 1 | 2019 | 2644 | 0.020 |
Why?
|
Reward | 1 | 2015 | 971 | 0.020 |
Why?
|
Carotid Artery Diseases | 1 | 2014 | 877 | 0.020 |
Why?
|
Genetic Testing | 1 | 2021 | 3537 | 0.020 |
Why?
|
Tachycardia, Ventricular | 1 | 2017 | 1304 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3882 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4853 | 0.020 |
Why?
|
Insurance, Health | 1 | 2019 | 2498 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2019 | 4431 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2079 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2669 | 0.020 |
Why?
|
Cell Count | 1 | 2011 | 1835 | 0.020 |
Why?
|
Lipids | 1 | 2018 | 3341 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2016 | 2822 | 0.020 |
Why?
|
Epithelium | 1 | 2011 | 1603 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2019 | 3744 | 0.020 |
Why?
|
Length of Stay | 1 | 2019 | 6426 | 0.020 |
Why?
|
Medicare | 1 | 2024 | 6770 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 2382 | 0.020 |
Why?
|
Recovery of Function | 1 | 2016 | 2979 | 0.020 |
Why?
|
Motor Activity | 1 | 2015 | 2715 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2850 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8830 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6228 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4176 | 0.010 |
Why?
|
Liver | 1 | 2020 | 7529 | 0.010 |
Why?
|
Overweight | 1 | 2015 | 2417 | 0.010 |
Why?
|
Pain Measurement | 1 | 2013 | 3551 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36429 | 0.010 |
Why?
|
Anticoagulants | 1 | 2016 | 4812 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 12990 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7391 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2015 | 5779 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36192 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2017 | 7879 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30054 | 0.010 |
Why?
|